CAS Number: 910463-68-2, which is a publicly recognized chemical identifier used to reference this specific molecular structure in scientific literature and research databases
According to a MarketsandMarkets report from July 2024, the global GLP-1 market is expected to reach $471 billion worldwide by 2032
EMA (accessed 2 September 2025)
In addition to the effects beyond weight loss of semaglutide on proteins related to CVD (as discussed above), other significantly regulated proteins in this analysis have previously been implicated in other conditions such as Alzheimers disease (TNC 58 , granulin 59,60 ), T2D (sFRP4 (refs
This powerhouse molecule has the remarkable ability to neutralize harmful free radicals, safeguarding liver cells from oxidative stress and damage
Its FDA-approved under the names Zepbound (for weight loss) and Mounjaro (for type 2 diabetes)